Frontiers in Oncology | Cancer Immunity and Immunotherapy

Case Report

Accepted on 22 Oct 2025

Nivolumab-induced subacute cutaneous lupus erythematosus in a patient with sigmoid colon cancer: A case report and review of the literature

in Cancer Immunity and Immunotherapy

Li Chang
Zhang Jianglin
Zhaojun Sun
YOUYOU ZHOU
Lixiong Zheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1674823

106 views

Correction

Accepted on 22 Oct 2025

Correction: Analysis of the twelve cases of immune-related myocarditis caused by cadonilimab

in Cancer Immunity and Immunotherapy

Frontiers Production Office

Frontiers in Oncology

doi 10.3389/fonc.2025.1730005

Original Research

Accepted on 21 Oct 2025

Immune checkpoint inhibitor-induced toxicity: a real-world analysis of the role of BMI

in Cancer Immunity and Immunotherapy

Calogera Claudia Spagnolo
Rosaria Maddalena Ruggeri
Angela Alibrandi
Martina Laganà
Desirèe Speranza
Salvatore Cannavò
Massimiliano Berretta
Mariacarmela Santarpia

Frontiers in Oncology

doi 10.3389/fonc.2025.1659977

123 views

Case Report

Accepted on 21 Oct 2025

Serplulimab-Induced Thyroid Dysfunction in a Patient with Advanced Small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Lu Lu
Lingxiang Liu
Wentong Fang
Xiaojian Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1611425

104 views

Review

Accepted on 21 Oct 2025

Durvalumab Consolidation Therapy in Patients with Stage III Small Cell Lung Cancer after Concurrent Chemoradiation: A China-based Cost-effectiveness Analysis

in Cancer Immunity and Immunotherapy

Hui Zhang
Bikun Cai
Liu Yuhang
Mengyi Wang
Haonan Li
HONG WANG

Frontiers in Oncology

doi 10.3389/fonc.2025.1643022

157 views

Systematic Review

Accepted on 21 Oct 2025

Bibliometric Visualization of Lung Cancer Immunotherapy Resistance: A Decade of Research Progress (2014–2024)

in Cancer Immunity and Immunotherapy

Zhuo Yang
Lanlan Yang
Yuli Wang
Xiangyu Ren
Yajing Cui
YAN Li
Jianchun Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1656967

112 views

Review

Accepted on 21 Oct 2025

Rewiring Tumor Visibility: The Immunopeptidome as a Dynamic Interface Between Antigen Processing, Microenvironmental Stress, and Immune Recognition

in Cancer Immunity and Immunotherapy

Jinhong QI
Kangkang Zhao
Yunlan Huang
Linlin Chang
Baiyu Wang
Mingshi Ye

Frontiers in Oncology

doi 10.3389/fonc.2025.1691719

113 views

Case Report

Published on 20 Oct 2025

Case Report: Dialysis following sintilimab-induced stage 3 acute kidney injury: mechanism investigation and management strategies

in Cancer Immunity and Immunotherapy

Bin Shan
Mengjiao Li
Ruixia Yang
Guanqi Wang
Juan Hou
Tianjiao Wen

Frontiers in Oncology

doi 10.3389/fonc.2025.1632740

538 views

Original Research

Published on 17 Oct 2025

Analysis of the twelve cases of immune-related myocarditis caused by cadonilimab

in Cancer Immunity and Immunotherapy

Po Chen
Zijing Zhao
Haiying Zheng
Jinlan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1671973

485 views

Original Research

Accepted on 16 Oct 2025

Transcriptomic Analysis Reveals TME-Mediated Macrophage IFIT1 Upregulation and CX3CR1 Suppression Drive Osteosarcoma Progression

in Cancer Immunity and Immunotherapy

Keyi Wang
Huanyang He
Jiamin Liang
Yuangang Su
Jinmin Zhao
Qian Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1686854

236 views

Case Report

Accepted on 16 Oct 2025

IL-6 Suppression: a Potential Strategy for Mitigating Severe Immune-Related Adverse Events in Nivolumab and Ipilimumab Therapy for Malignant Pleural Mesothelioma

in Cancer Immunity and Immunotherapy

Asako Yanagisawa
Takumi Fukaya
Kento Noda
Hiroshi Kojima
Hidefumi Shimizu

Frontiers in Oncology

doi 10.3389/fonc.2025.1671503

181 views

Case Report

Accepted on 16 Oct 2025

Dual Checkpoint Inhibition with Bevacizumab Yields Dramatic Response in Synchronous Double Primary HCC and ICC with Lung Metastasis

in Cancer Immunity and Immunotherapy

Yu-cheng He
Xin-ye Dai
Ying-hao Lv
Xiao-juan Yang
Qing-yun Xie
Si-nan Xie
Yun-shi Cai
Feng-wei Gao
Tian Lan

Frontiers in Oncology

doi 10.3389/fonc.2025.1670818

139 views

Mini Review

Accepted on 16 Oct 2025

Decoding the Immune Microenvironment in Osteosarcoma: New Insights into Checkpoints, Vaccines, and CAR-T Cells

in Cancer Immunity and Immunotherapy

Haitian Wang
Zhu Tongtong
Kunpeng Yang
Chenkai Xu
Zhaoyi Zhang
Guangyao Liu
Hongge Ren

Frontiers in Oncology

doi 10.3389/fonc.2025.1702219

Case Report

Published on 16 Oct 2025

Case Report: Diagnosis and treatment of giant thoracodorsal liposarcoma

in Cancer Immunity and Immunotherapy

Kailin Liu
Baoyan Zhao
Ningning Ren
Peng Zhao
Zhihao Wang
Xia Li
Yuyang Li
Chong Geng

Frontiers in Oncology

doi 10.3389/fonc.2025.1570796

1,021 views

Mini Review

Accepted on 14 Oct 2025

Integrated Molecular and Microenvironmental Drivers of Drug Resistance in Gastrointestinal Cancers: Mechanisms, Immunotherapy Challenges, and Precision Strategies

in Cancer Immunity and Immunotherapy

Heng Xu
Jiaan Lu
Jiangying Wu
Kangling Zhang
Jingqi Feng
Ziqi Gao
Xuancheng Zhou
Ziye Zhuang
Xiaolin Zhong

Frontiers in Oncology

doi 10.3389/fonc.2025.1675745

170 views

Case Report

Accepted on 14 Oct 2025

Complete Response of Advanced HER2-Amplified Lung Adenocarcinoma to Cadonilimab Combined with Disitamab Vedotin: A Case Report

in Cancer Immunity and Immunotherapy

Yue Li
Keru Ma
Hao Wang
Zongying Liu
Zhuying Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1587210

135 views